HIGHLIGHTS
- who: Khalid Rashid et al. from the Institute for Experimental Cancer Research, University Medical Centre Schleswig-Holstein (UKSH) have published the paper: CD95L Inhibition Impacts Gemcitabine-Mediated Effectsand Non-Apoptotic Signaling of TNF- and TRAIL in Pancreatic Tumor Cells, in the Journal: Cancers 2021, 5458 of 24/09/2021
- what: The authors show that gemcitabine stimulates the expression of proinflammatory cytokines such as IL6 and IL8 under the influence of the CD95/CD95L system and the pharmacological inhibitor sCD95Fc substantially reduced the expression in two cell lines PancTuI-luc and A818-4. In Supplementary Figure . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.